metalloproteinasessuch
matrix
metalloproteinas
mmp
disintegrin
metalloproteinas
adam
involv
variou
diseas
nervou
system
also
contribut
nervou
system
develop
synapt
plastic
neuroregener
upon
injuri
mmp
adam
proteolyt
cleav
mani
substrat
includ
extracellular
matrix
compon
also
signal
molecul
receptor
neuroinfecti
diseas
associ
neuroinflamm
mmp
adam
regul
bloodbrain
barrier
breakdown
bacteri
invas
neutrophil
infiltr
cytokin
signal
specif
broadspectrum
inhibitor
mmp
adam
experiment
shown
decreas
neuroinflamm
brain
damag
diseas
excess
neuroinflamm
common
denomin
pneumococc
mening
multipl
sclerosi
therebi
improv
diseas
outcom
time
metalloproteinas
inhibit
appear
critic
effect
target
cascad
pathophysiolog
process
lead
brain
damag
without
inhibit
neuroregen
effect
metalloproteinas
critic
role
metalloproteinas
neuron
repair
mechan
regener
late
recogn
origin
idea
chronic
mmp
inhibit
need
conceptu
revis
recent
accumul
research
urg
second
chanc
metalloproteinas
inhibitor
whichwhen
correctli
appli
dosedharbor
potenti
improv
outcom
differ
neuroinflammatori
diseas
publish
note
springer
natur
remain
neutral
regard
jurisdict
claim
publish
map
institut
affili
matrix
metalloproteinas
mmp
disintegrin
metalloproteinas
adam
belong
class
metzincin
metalloproteinas
contain
conserv
met
residu
activ
site
use
zinc
ion
enzymat
reaction
metalloproteinas
involv
mani
neurolog
condit
also
contribut
crucial
neurophysiolog
function
synapt
plastic
neuroregener
via
regul
stem
cell
biolog
remyelin
differ
mammalian
mmp
describ
type
defin
substrat
specif
collect
mmp
degrad
compon
extracellular
matrix
ecm
apart
degrad
ecm
mmp
also
abl
cleav
adhes
molecul
receptor
growth
factor
indic
involv
mmp
cell
migrat
signal
differenti
cell
surviv
apoptosi
angiogenesi
inflamm
adam
also
capac
degrad
remodel
compon
ecm
best
character
function
protein
ectodomain
shed
therebi
process
releas
matur
protein
eg
membraneanchor
precursor
patholog
condit
central
nervou
system
cn
metalloproteinas
deriv
infiltr
leukocyt
neutrophil
macrophag
lymphocyt
brainresid
cell
microglia
astrocyt
neuron
metalloproteinas
capac
extens
tissu
destruct
activ
tightli
regul
control
catalyt
activ
mmp
regul
four
differ
level
name
gene
express
compartment
proenzym
activ
enzym
inhibit
prommp
kept
catalyt
inact
state
activ
proteolyt
cleavag
prodomain
modif
prodomain
cystein
thiol
group
import
inflammatori
infecti
process
reactiv
oxygen
speci
ro
potenti
activ
mmp
via
oxid
prodomain
thiol
group
mmp
inactiv
might
achiev
natur
inhibitor
tissu
inhibitor
metalloproteinas
timp
promin
one
bind
catalyt
site
mmp
four
timp
abl
termin
mmp
activ
mani
timp
target
multipl
metalloproteinas
also
strict
specif
timp
inhibit
contribut
mmp
bloodbrain
barrier
bbb
integr
demonstr
first
time
earli
induc
bbb
breakdown
intracerebroventricular
administr
effect
prevent
simultan
administr
subsequ
find
elev
level
cerebr
insult
first
time
establish
link
mmp
inflamm
cn
intracerebr
inject
lipopolysaccharid
lp
mimick
bacteri
brain
infectionsincreas
mrna
level
induc
bbb
disrupt
action
bloodbrain
barrier
open
associ
morpholog
redistribut
tight
junction
tj
adheren
junction
aj
protein
membran
cytoplasm
differ
neurolog
patholog
mmp
report
degrad
tj
basal
lamina
protein
therebi
induc
bbb
leakag
subsequ
neutrophil
infiltr
brain
edema
hemorrhag
role
bbb
open
intens
studi
cerebr
ischemia
model
found
play
import
role
initi
bbb
open
increas
activ
associ
degrad
tj
protein
occludin
gelatinas
b
abl
degrad
major
compon
basal
lamina
type
iv
collagen
laminin
fibronectin
surround
cerebr
blood
vessel
thu
increas
bbb
permeabl
vitro
vivo
capabl
degrad
occludin
therebi
particip
tj
degrad
experiment
data
propos
play
profound
role
delay
bbb
breakdown
deriv
mostli
brain
microvascular
endotheli
cell
infiltr
neutrophil
infiltr
neutrophil
contain
store
tertiari
granul
gelatinas
granul
rapidli
releas
upon
enter
site
injuri
level
critic
increas
bacteri
mening
elev
level
associ
bbb
damag
neurolog
sequela
experiment
ischem
stroke
increas
neutrophilderiv
critic
involv
state
system
inflamm
sustain
degrad
tj
basal
lamina
protein
lead
exacerb
brain
injuri
apart
two
gelatinas
mmp
influenc
bbb
integr
abl
degrad
laminin
gelatin
ecadherin
proteoglycan
fibronectin
demonstr
mediat
bbb
open
lpsinduc
neuroinflamm
therebi
facilit
neutrophil
infiltr
collagenas
preferenti
cleav
helic
collagen
ecm
report
activ
andor
upregul
vessel
bbb
impair
bacteri
mening
cerebrospin
fluid
csf
level
upregul
associ
bbb
damag
repeat
lumbar
punctur
bacteri
mening
patient
reveal
level
regul
independ
correl
csf
granulocyt
cell
count
indic
mmp
might
secret
infiltr
neutrophil
also
brainresid
cell
neural
vascular
barrier
function
also
regul
adam
shown
control
neural
vascular
barrier
function
upon
hypox
stimuli
diminish
brain
microvascular
endotheli
cell
effect
prevent
specif
inhibit
activ
cleav
vecadherin
promot
leukocyt
migrat
interendotheli
junction
first
describ
mmp
found
degrad
collagen
follow
contribut
mmp
mostli
focus
abil
degrad
ecm
compon
recent
data
suggest
howev
mmp
much
wider
rang
activ
includ
nonmatrix
substrat
instead
cluster
mmp
togeth
function
ecm
degrad
park
et
al
suggest
categor
rather
accord
role
inflamm
tabl
fig
summar
function
select
metalloproteinas
proand
antiinflammatori
process
establish
effect
immun
reaction
invad
pathogen
neutrophil
must
migrat
effici
along
chemotact
gradient
extravas
blood
vessel
toward
site
infect
metalloproteinas
demonstr
involv
process
degrad
ecm
promot
effector
cell
extravas
also
regul
chemotact
gradient
first
demonstr
shown
process
aminotermin
fragment
therebi
increas
chemoattract
properti
effici
recruit
neutrophil
hand
shown
inactiv
monocyt
chemotact
protein
also
known
chemokin
cc
motif
ligand
remov
aminotermin
tetrapeptid
convert
antagonist
chemokin
receptor
conceptu
find
show
mmp
act
effector
also
regul
inflammatori
respons
subsequ
also
shown
specif
substrat
mmp
close
relat
chemokin
proteolyt
cleav
truncat
product
potent
antagonist
respect
chemokin
receptor
apart
influenc
activ
cc
motif
chemokin
mmp
also
contribut
cxcchemokin
function
stromal
cellderiv
factor
alpha
also
known
process
inactiv
truncat
form
process
demonstr
highli
neurotox
properti
eleg
studi
singl
doubl
knockout
mice
reveal
mmp
work
synergist
initi
step
neutrophil
recruit
injuri
site
increas
potenc
cxcchemokin
ligand
activ
murin
lpsinduc
cxc
chemokin
lix
similar
human
neutrophilrecruit
chemokin
depend
cleav
lix
promot
enhanc
chemotaxi
neutrophil
infiltr
lpsstimul
site
clearli
diminish
mice
studi
show
requir
extravas
migrat
neutrophil
play
crucial
role
orchestr
initi
inflammatori
respons
upon
lp
stimul
therebi
indic
chemoattract
rather
collagen
primari
substrat
nevertheless
collagen
process
also
act
chemotact
peptid
neutrophil
chemotaxi
report
cleav
chang
biolog
activ
demonstr
contrast
potent
inactiv
multipl
cleavag
suggest
regulatori
role
earli
activ
subsequ
inactiv
addit
direct
effect
mmp
chemokin
mmp
might
also
regul
express
chemokin
receptor
therebi
provid
addit
level
proteinas
control
leukocyt
migrat
besid
directli
process
chemokin
alter
biolog
function
mmp
also
indirectli
influenc
avail
activ
chemokin
cleav
accessori
macromolecul
bind
therebi
mmp
exhibit
addit
way
regul
leukocyt
migrat
involv
cleavag
turn
releas
also
known
kc
therebi
indirectli
gener
chemotact
gradient
direct
neutrophil
migrat
site
injuri
consequ
neutrophil
infiltr
massiv
reduc
mice
site
injuri
impair
transepitheli
migrat
mmp
also
regul
chemotact
gradient
role
less
well
understood
seem
critic
establish
eotaxin
chemotact
gradient
leukocyt
recruit
allergeninduc
asthmat
mice
show
leukocyt
accumul
lung
parenchyma
decreas
level
notabl
indirect
proinflammatori
effect
distinct
discuss
direct
antiinflammatori
function
via
chemokin
cleavag
inactiv
addit
contribut
gener
chemotact
gradient
allergeninduc
asthmat
mice
mice
show
diminish
chemoattract
level
summari
tabl
metalloproteinas
regulatori
function
neuroinflamm
mmp
import
regul
inflamm
control
cytokin
activ
chemotact
gradient
therebi
manipul
leukocyt
migrat
tabl
contain
select
intens
studi
metalloproteinas
substrat
specif
exclud
classic
substrat
ecm
degrad
involv
bbb
breakdown
inflamm
special
attent
paid
concept
metalloproteinas
involv
inflamm
termin
eg
cleavag
inactiv
induct
repair
process
activ
egfr
signal
studi
demonstr
mmp
import
regul
inflamm
control
chemokin
activ
chemotact
gradient
therebi
manipul
leukocyt
migrat
apart
gener
chemotact
gradient
recruit
leukocyt
site
infect
mmp
also
capac
directli
activ
regul
cytokin
signal
proinflammatori
cytokin
need
proteolyt
activ
enzym
ice
recent
renam
discoveri
activ
describ
process
human
precursor
biolog
activ
form
addit
lesser
extent
collagenaseswa
found
degrad
activ
longer
incub
period
indic
regulatori
role
mmp
activ
inactiv
physiolog
condit
convers
membranebound
activ
solubl
form
attribut
enzym
tace
known
also
see
next
section
even
specif
best
convertor
lesser
physiolog
relev
extent
capac
cleav
activ
seem
act
anoth
physiolog
convertor
contrast
activ
proinflammatori
cytokin
mmp
also
abl
activ
transform
growth
vitro
restrain
mononuclear
inflamm
therebi
indic
overal
regulatori
effect
mmp
inflamm
upon
destruct
bbb
neutrophil
enter
central
nervou
system
gener
chemotact
gradient
secret
abl
cleav
activ
collagenas
contribut
bbb
leakag
degrad
extracellular
matrix
ecm
adam
mmp
directli
contribut
neuroinflamm
activ
proinflammatori
cytokin
like
microgliamacrophag
green
cell
illustr
summar
import
role
adam
mmp
induct
neuroinflamm
thorough
pictur
found
tabl
simplic
bbb
depict
without
pericyt
astrocyt
illustr
design
inspir
khokha
et
al
adam
infect
inflammatori
respons
enzym
tace
origin
thought
mmp
effect
inhibit
synthet
metalloproteinas
inhibitor
later
found
belong
adam
famili
identifi
show
distinct
specif
shed
membranebound
therebi
releas
biolog
activ
proinflammatori
proapoptot
function
cell
releas
reduc
indic
princip
convert
enzym
solubl
signal
via
bind
tnf
receptor
wherea
membranebound
act
preferenti
bind
regul
tnf
signal
even
complex
sinc
also
shed
act
decoy
receptor
sequest
solubl
away
receptor
defici
myeloid
cell
protect
mice
endotoxininduc
septic
shock
prevent
increas
serum
level
convers
select
inhibit
mice
show
enhanc
signal
elev
serum
level
increas
mortal
lpsinduc
sepsi
also
describ
involv
transsign
shed
receptor
turn
complex
interact
membran
receptor
ubiquit
express
mani
cell
type
leukocyt
express
lselectin
surfac
involv
roll
inflam
vascular
endothelium
follow
firm
adhes
transmigr
lselectin
rapidli
cleav
near
leukocyt
cell
surfac
transmigr
neutrophil
show
slower
roll
better
adhes
faster
recruit
site
inflamm
impair
lselectin
shed
respons
earli
neutrophil
recruit
mucos
barrier
shown
import
egfr
activ
egfrdefici
mice
show
similar
featur
subsequ
shown
major
convertas
egfr
ligand
epiregulin
amphiregulin
heparinbind
egflik
growth
factor
wherea
emerg
major
sheddas
egf
betacellulin
intestin
inflamm
egfr
ligand
shed
necessari
product
antimicrobi
peptid
epitheli
cell
later
regener
addit
associ
shed
lselectin
activ
cell
therebi
regul
recruit
adapt
immun
cell
adam
also
abl
manipul
immun
signal
via
ectodomain
shed
notch
receptor
requir
activ
notch
activ
found
regul
atop
barrier
function
suppress
epitheli
cytokin
synthesi
addit
shown
involv
neutrophil
apoptosi
resolut
acut
inflamm
microglia
brainresid
immun
cell
involv
import
role
healthi
infect
injur
brain
includ
postnat
neurodevelop
neural
plastic
phagocytosi
upon
stimul
microglia
polar
differ
microgli
subset
polar
state
roughli
divid
classic
activ
microglia
adapt
proinflammatori
phenotyp
secret
altern
activ
cell
produc
cytokin
involv
inflamm
termin
restor
homeostasi
promot
tissu
repair
mmp
express
produc
microglia
site
infect
inflamm
macrophag
two
differ
differ
mmp
depict
proinflammatori
role
bbb
open
cytokin
activationi
secret
microglia
involv
remodel
factor
repair
kohkha
et
al
suggest
mmpsapart
differenti
express
subsetsmight
also
contribut
phenotyp
polar
regul
cytokin
growth
factor
avail
microglia
polar
toward
phenotyp
gain
interest
therapeut
strategi
differ
neurolog
disord
understand
critic
role
metalloproteinas
process
need
investig
collect
find
demonstr
crucial
role
metalloproteinas
initi
neuroinflammationinclud
bbb
breakdown
chemokin
activ
neutrophil
recruit
proinflammatori
cytokin
productionbut
also
inflamm
termin
subsequ
repair
via
chemokin
cytokin
inactiv
involv
angiogenesi
neurogenesi
gliosi
damag
therefor
inhibit
metalloproteinas
acut
inflammatori
process
lead
benefici
outcom
wherea
inhibit
repair
process
might
detriment
brain
protect
infecti
agent
special
barrier
includ
skull
mening
restrict
bbb
make
brain
microbiolog
steril
site
physiolog
condit
subsequ
infecti
diseas
cnssuch
bacteri
meningitisoccur
compar
low
level
might
detriment
consequ
describ
metalloproteinas
regul
barrier
function
bbb
also
mucos
epithelium
play
multipl
role
initi
regul
inflamm
therebi
essenti
involv
cn
infect
establish
cn
infect
bacteri
pathogen
success
colon
host
gain
access
subarachnoid
space
brain
parenchyma
common
caus
agent
bacteri
meningitisstreptococcu
pneumonia
neisseria
meningitidi
haemophilu
influenza
type
b
colon
human
nasopharynx
transmit
via
respiratori
rout
case
bacteri
mening
origin
bacteremia
nasopharyng
pathogen
gain
access
blood
stream
subsequ
cross
bbb
bloodcsf
barrier
bcsfb
caus
pathogen
bacteri
meningitiswhich
caus
mening
mostli
neonat
elderli
immunocomprom
patient
group
b
streptococcu
gb
escherichia
coli
listeria
monocytogen
colon
intestin
mucosa
access
circul
invad
brain
bacteri
mening
might
also
aris
focal
infect
vicin
brain
ie
otiti
media
sinus
dental
abscess
local
spread
rather
bacteremia
underli
bacteri
brain
invas
final
breach
anatom
brain
barrier
trauma
surgeri
may
also
lead
bacteri
mening
among
bacteri
mening
pneumococc
mening
pm
especi
detriment
caus
high
mortal
lead
longlast
neurofunct
deficit
neurofunct
sequela
pm
includ
hear
loss
epilepsi
cerebr
palsi
well
behavior
cognit
deficit
brain
damag
pm
character
cortic
necrosi
apoptosi
dentat
gyru
granular
cell
progenitor
hippocampu
part
respons
behavior
cognit
deficit
experiment
model
cortic
necrosi
found
earli
h
infect
might
aris
consequ
focal
global
ischemia
neural
cell
death
caus
multipl
factor
includ
bacteri
toxin
excess
inflammatori
reaction
host
inflammatori
mediat
cytokin
chemokin
reactiv
oxygen
nitrogen
speci
mmp
releas
recruit
neutrophil
endotheli
cell
leptomening
macrophag
brainresid
microglia
astrocyt
contribut
pathogen
erad
also
act
neurotoxin
induc
neuron
damag
moreov
pm
induc
damag
hair
cell
spiral
ganglion
neuron
inner
ear
provok
sensorineur
hear
impair
survivor
infant
rat
pm
model
increas
csf
level
acut
infect
posit
correl
increas
hear
loss
surviv
anim
pathogenesi
involv
inflammatori
process
induc
brain
damag
mening
intens
studi
differ
anim
model
upon
bacteri
invas
cn
wide
rang
cytokin
produc
secret
csf
experiment
pneumococc
mening
increas
csf
level
alreadi
detect
h
infect
peak
h
infect
sinc
level
csf
increas
evid
neutrophil
recruit
brainresid
cell
consid
contribut
significantli
cytokin
product
result
bacteri
prolifer
excess
inflammatori
reaction
take
place
csf
bbb
breakdown
caus
brain
edema
via
leakag
plasma
cn
increas
intracrani
pressur
hydrocephalu
cerebr
ischemia
patient
bacteri
mening
cerebrovascular
complic
frequent
observ
vascul
caus
cerebr
infarct
hemorrhag
subsequ
cortic
damag
mening
data
clinic
experiment
studi
shed
light
onto
crucial
role
metalloproteinas
pathogenesi
bacteri
mening
neuroinfecti
diseas
metalloproteinasesexpress
activ
respons
invad
pathogencontribut
acut
neuroinflammatori
reaction
damag
upon
bacteri
invas
might
also
involv
later
diseas
resolut
inflamm
repair
mechan
bacteri
mening
express
activ
metalloproteinas
inhibitor
alter
compar
physiolog
condit
experiment
pm
infant
rat
transcript
upregul
csf
cell
wherea
express
remain
unaffect
brain
tissu
express
significantli
upregul
express
level
remain
unchang
upregul
mostli
releas
infiltr
neutrophil
specif
hallmark
bacteri
mening
found
neuroinflammatori
diseas
induc
increas
barrier
permeabl
via
proteolyt
cleavag
tight
junction
protein
occludin
meningococc
neuroinfect
experiment
data
mening
caus
heatinactiv
n
meningitidi
show
signific
upregul
mrna
express
stabl
express
protein
level
csf
correl
level
concentr
peak
h
intracistern
infect
pneumonia
csf
detect
earli
min
intracistern
infect
indic
earli
releas
brainresid
cell
experiment
model
recruit
infiltr
neutrophil
contribut
peak
level
h
infect
gelatinas
activ
andor
associ
occurr
cortic
necrot
lesion
experiment
pm
initi
neuroinflamm
play
crucial
role
releas
turn
act
stimulu
induc
mmp
upregul
via
posit
feedback
loop
fact
second
potent
activ
apart
remain
unchang
bacteri
mening
emphas
import
earli
neuroinflammatori
process
addit
increas
level
express
also
increas
csf
infant
rat
pm
howev
short
delay
timp
suggest
regul
protein
degrad
cytokin
shed
pm
therebi
control
metalloproteinaseinduc
neuroinflamm
experiment
pm
upregul
howev
exce
compensatori
effect
acut
phase
imbal
mmp
timp
bacteri
mening
therefor
implic
key
event
pathophysiolog
diseas
experiment
model
cerebr
ischemia
mice
show
bbb
preserv
reduc
level
tight
junction
protein
degrad
subsequ
better
outcom
defici
experiment
pm
howev
shown
associ
impair
bacteri
clearanc
blood
spleen
without
show
impact
clinic
cours
diseas
leukocyt
infiltr
subarachnoid
space
bacteri
titer
brain
noninfecti
experiment
model
brain
damag
shown
direct
effect
laminin
degrad
associ
hippocamp
apoptosi
matrix
metalloproteinas
express
profil
patient
bacteri
mening
consist
data
gener
experiment
set
patient
bacteri
mening
csf
level
found
elev
wherea
csf
level
remain
unaffect
similar
anim
model
level
also
found
upregul
wherea
significantli
downregul
compar
control
patient
one
week
infect
continu
highli
express
wherea
reduc
compar
acut
phase
infect
pediatr
pm
level
found
correl
csf
cell
count
high
csf
level
risk
factor
fatal
outcom
develop
neurolog
sequela
caus
pathogen
determin
inflammatori
respons
patient
bacteri
mening
pneumococc
mening
associ
significantli
increas
mortal
elev
level
compar
mening
caus
n
meningitidi
h
influenza
tubercul
mening
tbm
aris
rare
extrapulmonari
form
tuberculosi
associ
neurofunct
complic
patient
tbm
level
found
elev
high
level
associ
late
neurofunct
deficit
adjuv
dexamethason
tbm
shown
reduc
level
earli
treatment
might
repres
one
way
dexamethason
reduc
mortal
tbm
despit
benefici
effect
dexamethason
term
mortal
could
success
prevent
sever
disabl
involv
metalloproteinas
bbb
integr
viral
neuroinfect
intens
review
elsewher
clinic
data
patient
viral
mening
report
elev
csf
level
compar
control
patient
level
correl
neutrophil
cell
number
csf
involv
metalloproteinas
viral
neuroinfect
mostli
analyz
experiment
studi
though
japanes
enceph
viru
jev
arthropodborn
viru
major
caus
acut
encephalopathi
children
vitro
express
jev
infect
mediat
via
activ
gener
ro
express
well
upregul
mice
infect
jev
overexpress
associ
diseas
sever
experiment
herpessimplex
viru
enceph
hse
upregul
insuffici
counterbalanc
result
loss
collagen
type
iv
indic
role
pathogenesi
hse
vitro
west
nile
viru
wnv
infect
human
endotheli
cell
show
signific
upregul
multipl
mmp
subsequ
loss
tight
junction
protein
effect
success
prevent
mmp
inhibitor
level
also
found
elev
wnvinfect
mice
well
patient
suggest
play
role
mediat
wnv
entri
cn
hiv
infect
mechan
postul
involv
infiltr
hivinfect
leukocyt
cn
caus
neuropatholog
vitro
mechan
seem
reli
upregul
associ
reduct
tight
junction
protein
experiment
hiv
infect
envelop
protein
increas
express
subsequ
laminin
reduct
caus
increas
bbb
permeabl
patient
hivassoci
dementia
csf
level
increas
might
reflect
link
symptomat
neurolog
diseas
increas
mmp
activ
detriment
effect
bbb
integr
might
contribut
transendotheli
migrat
hivinfect
cell
cn
develop
hivassoci
neurolog
damag
mous
adenoviru
infect
increas
level
brain
addit
ex
vivo
data
reveal
produc
astrocyt
microglia
respons
mous
encephalit
might
contribut
bbb
disrupt
enceph
may
also
induc
bbb
breakdown
reduc
surfac
express
tj
protein
occludin
murin
coronavirusinduc
viral
enceph
induc
express
plu
express
exclus
local
astrocyt
wherea
origin
infiltr
cell
increas
mmp
timp
level
also
associ
increas
viral
replic
neurotrop
mous
hepat
infect
sinc
mmp
adam
central
regul
mediat
neuroinflamm
develop
neuron
damag
bacteri
mening
inhibit
these
enzym
acut
infect
postul
promis
therapeut
intervent
improv
diseas
outcom
last
three
decad
mani
differ
inhibitor
test
rodent
model
bacteri
mening
tabl
matrix
metalloproteinas
adam
function
ecm
degrad
enzym
sheddas
therebi
control
bbb
breakdown
product
inflammatori
cytokin
experiment
bacteri
mening
mmp
adam
inhibitor
significantli
reduc
csf
level
mmp
proinflammatori
cytokin
notabl
csf
level
also
significantli
reduc
mmp
inhibitor
mmpi
without
specif
ie
trocad
indic
mmpi
abl
indirectli
reduc
proinflammatori
cytokin
product
apart
direct
inhibit
mmpi
partial
preserv
bbb
integr
prevent
ecm
protein
degrad
pm
mous
model
reduc
neuroinflamm
therebi
improv
surviv
anim
without
antibiot
therapi
notabl
remark
differ
differ
mous
rat
strain
term
bbb
breakdown
prevent
metalloproteinas
inhibitor
lpsinduc
neuroinflamm
consequ
bacteri
mening
associ
inflammatori
reaction
cerebrovascular
complic
frequent
observ
patient
focal
ischemia
caus
vascul
result
cortic
necrosi
mening
breakdown
bbb
excess
neuroinflammatori
reaction
crucial
step
develop
cerebr
ischemia
sinc
metalloproteinas
central
regul
bbb
breakdown
bacteri
mening
discuss
inhibit
acut
diseas
valuabl
therapeut
strategi
reduc
cortic
necrosi
pretreat
treatment
earli
cours
diseas
mmpi
associ
reduc
cortic
necrosi
pneumococc
mening
lower
rate
intracerebr
hemorrhag
meningococc
mening
neuroprotect
effect
howev
reduc
applic
inhibitor
delay
time
antibiot
therapi
first
appear
diseas
symptom
earli
inhibit
mmp
bacteri
mening
might
respons
overal
reduct
neuroinflammatori
reaction
reduc
bbb
breakdown
cytokin
product
therebi
limit
pathophysiolog
consequ
diseas
apoptosi
immatur
neuron
dentat
gyru
hippocampu
bacteri
mening
caus
bacteri
toxin
also
excess
inflammatori
reaction
host
sever
metalloproteinas
inhibitor
inhibit
ie
ro
found
prevent
hippocamp
apoptosi
howev
inhibitor
unabl
prevent
neural
cell
death
hippocampu
hand
trocadewithout
specif
profilesuccess
prevent
hippocamp
apoptosi
directli
involv
hippocamp
cell
death
via
degrad
laminin
inhibit
explain
neuroprotect
effect
trocad
bacteri
mening
protect
effect
hippocamp
neuron
lowerbut
still
presentwhen
trocad
therapi
initi
togeth
antibiot
time
symptom
onset
apoptosi
dentat
gyru
granular
cell
progenitor
found
hippocampu
human
anim
model
bacteri
mening
correl
behaviour
learn
deficit
increas
hippocamp
apoptosi
associ
impair
learn
memori
perform
rat
pm
protect
hippocamp
apoptosi
improv
learn
perform
rat
pm
similarli
pminfect
rat
treat
trocad
plu
daptomycin
observ
reduct
hippocamp
apoptosi
associ
signific
improv
learn
memori
function
therapi
significantli
protect
hippocamp
neuron
prevent
pminduc
learn
memori
impair
neonat
rat
notabl
three
therapi
also
significantli
protect
cortic
necrosi
might
also
posit
influenc
learn
memori
perform
pm
correspondingli
adult
rat
inhibit
prevent
cognit
impair
pm
possibl
due
observ
success
preserv
bbb
integr
acut
infect
bacteri
mening
induc
sensorineur
hear
loss
damag
hair
cell
spiral
ganglion
neuron
inner
ear
pm
csf
level
acut
infect
posit
correl
increas
hear
threshold
infect
treatment
doxycyclin
trocad
plu
daptomycin
significantli
reduc
csf
level
proinflammatori
cytokin
significantli
improv
hear
threshold
pm
doxycyclinewith
broad
spectrum
mmp
inhibit
profilepreserv
spiral
ganglion
neuron
pminduc
cell
death
overal
reduct
neuroinflamm
therapi
might
attribut
reduc
concentr
ototox
compound
cochlear
duct
therebi
prevent
ototox
damag
spiral
ganglion
neuron
hair
cell
cochlea
two
metalloproteinas
inhibitorsro
highdos
high
specif
report
increas
mortal
acut
bacteri
mening
administr
earli
infect
experiment
model
pm
mice
mortal
significantli
increas
despit
treatment
antibiot
indic
may
play
essenti
role
infect
inflamm
necessari
host
defens
earli
stage
infect
pm
inhibit
potent
inhibitor
might
therefor
rather
detriment
benefici
despit
neuroprotect
survivor
especi
appli
time
major
contributor
initi
host
respons
multipl
sclerosi
ms
chronic
autoimmun
diseas
cn
lead
progress
deterior
motor
sensori
veget
cognit
function
pathogenesi
ms
encompass
featur
acut
subacut
inflamm
chronic
neurodegener
mainli
result
former
similar
neuroinfecti
diseas
subsequ
neuroinflamm
brain
damag
ms
also
cover
present
review
million
patient
worldwid
make
ms
import
neurolog
diseas
young
adulthood
diseas
affect
predominantli
caucasian
highest
preval
popul
northern
european
origin
caus
ms
remain
unknown
strong
evid
interplay
genet
environment
factor
smoke
lack
sun
exposurevitamin
defici
epsteinbarr
viru
ebv
infect
respons
suscept
cours
diseas
classic
understand
ms
pathogenesi
base
three
essenti
paradigm
howev
recent
year
increas
bodi
evid
led
modif
extens
paradigm
demyelin
restrict
white
matter
extend
steadili
grey
matter
cours
diseas
neuron
loss
cellular
substrat
disabl
worsen
occur
cours
demyelin
even
larger
extent
outsid
independ
focal
demyelin
addit
seem
relev
fraction
patient
form
ms
white
matter
demyelin
occur
phenotyp
character
ms
subtyp
base
distinct
molecular
mechan
accord
current
understand
continuum
sever
pathogenet
pathway
may
predomin
certain
stage
diseas
durat
lastli
success
bcell
target
therapi
revolution
understand
autoimmun
respons
ms
b
cell
seem
orchestr
drive
diseas
directli
indirectli
via
cell
cell
acut
progress
phase
import
role
mmp
effector
molecul
inflammatori
tissu
damag
recogn
last
centuri
progress
understand
ms
pathogenesi
rather
increas
import
ad
complex
regul
pathogenesi
diseas
focal
open
bbb
one
initi
event
cours
acut
exacerb
ms
follow
invas
bloodderiv
leucocyt
perivascular
brain
parenchyma
eventu
lead
format
focal
lesion
manifest
clinic
attack
leukocyt
well
cell
form
bbb
endotheli
cell
astrocyt
produc
mmp
timp
bbb
leakag
result
mmp
upregul
compens
timp
activ
basal
membran
type
iv
collagen
primari
barrier
structur
bbb
main
substrat
gelatinas
make
specif
effector
molecul
leukocyt
extravas
brain
parenchyma
ms
lesion
upregul
demonstr
immunohistochemistri
transcript
level
correl
inflammatori
activ
lesion
experiment
autoimmun
enceph
eae
model
ms
upregul
correl
cours
diseas
sever
contrast
knockout
mice
defici
less
suscept
eae
induct
delayedtyp
hypersensit
dth
rat
model
protein
transcript
express
sever
mmp
increas
moreov
microinject
brain
parenchyma
led
demyelin
axon
damag
latter
part
independ
former
axon
damag
continu
even
integr
bbb
reestablish
fact
mmp
may
caus
direct
neuron
damag
import
concept
clinic
progress
ms
increas
express
also
chronic
phase
lesion
develop
may
contribut
chronic
smoulder
neuron
loss
eventu
lead
progress
deterior
neurolog
function
hand
csf
analysi
patient
activ
progress
ms
either
relaps
previou
year
presenc
lesion
gadolinium
enhanc
baselin
mri
higher
level
bcell
activ
marker
inact
progress
ms
patient
coincid
higher
level
neurofila
light
chain
measur
ongo
axon
damag
mbp
indic
demyelin
sever
group
demonstr
increas
csf
blood
ms
patient
level
correl
diseas
activ
higher
rrm
spm
vs
ppm
mri
activ
longitudin
studi
spm
patient
increas
ratio
preced
occurr
new
gadoliniumenhanc
lesion
studi
show
also
higher
median
level
trend
lower
patient
receiv
compar
placebo
recipi
similarli
steroid
treatment
use
intervent
therapi
acut
exacerb
ms
led
decreas
csf
promin
effect
patient
gadoliniumenhanc
lesion
support
function
role
bbb
breakdown
moreov
quantit
pcr
analysi
reveal
therapi
downregul
express
blood
leukocyt
patient
develop
neutral
antibodi
show
increas
mmp
circul
support
concept
antibodi
reduc
therapeut
efficaci
therapi
work
mmp
ms
restrict
mainli
due
fact
member
mmp
famili
could
quantifi
easili
highest
sensit
zymographi
mmp
elisa
need
becam
avail
year
baror
et
al
perform
comprehens
analysi
transcript
express
mmp
quantit
pcr
monocyt
well
b
cell
healthi
control
ms
patient
cell
type
specif
pattern
enzym
across
involv
member
mmp
famili
specif
increas
monocyt
ms
patient
observ
kouwenhoven
et
al
found
mrna
level
monocyt
elev
ms
differ
compar
control
studi
underlin
molecular
mechan
tissu
degrad
restrict
result
interplay
mani
mmp
mani
cellular
sourc
nevertheless
result
differ
investig
show
high
degre
congruenc
discrep
may
reflect
heterogen
characterist
ms
patient
investig
initi
mmp
consid
good
physiolog
growth
bad
ms
shown
tabl
overli
simplist
concept
revis
recent
year
effect
mmp
ecm
metabol
destruct
charact
includ
well
repar
function
depend
phase
ms
involv
oligodendrocyt
regrowth
cleav
remyelinationimpair
fibronectin
allow
remyelin
author
specul
low
level
contribut
persist
demyelin
chronic
ms
lesion
prevent
oligodendrocyt
matur
function
mmp
synaptogenesi
recogn
find
relev
concept
mmp
inhibit
could
use
therapeut
approach
ms
leucocyt
extravas
lesion
ceas
reestablish
bbb
microglia
major
sourc
mmp
cn
howev
known
whether
microgli
activ
contribut
activ
progress
ms
actual
benefici
reaction
preserv
tissu
integr
henc
clear
time
point
long
therapeut
mmp
inhibit
could
benefici
ms
base
evid
concern
role
mmp
bbb
open
lesion
format
mmp
inhibitor
mmpi
thought
ideal
class
compound
ms
therapi
late
develop
specif
mmpi
oncolog
follow
great
interest
neurolog
field
vitro
model
metastasi
show
dramat
reduct
dissemin
growth
tumor
cell
thought
transfer
suppress
bbb
transmigr
bloodderiv
leukocyt
ms
bolster
observ
current
therapi
later
natalizumab
downregul
mmp
part
mode
action
hypothesi
therapeut
effect
may
mediat
via
suppress
effect
express
cell
corrobor
reduct
migrat
across
artifici
bbb
number
hydroxam
acid
inhibitor
type
compound
inactiv
enzymat
activ
mmp
bind
catalyt
zinc
mmp
led
diseas
sever
attenu
eae
similarli
compound
reduc
capac
cell
migrat
across
vitro
bbb
model
howev
sever
reason
clinic
studi
never
start
oncolog
initi
promis
preclin
result
mmpi
confirm
clinic
trial
case
rheumatoid
arthriti
addit
depend
enzymat
target
profil
advers
event
specif
sign
toxic
recogn
chronic
dose
preclud
intend
longterm
use
mainten
therapi
ms
review
see
evid
role
mmp
tissu
repair
subacut
stabl
phase
diseas
suggest
longterm
mmp
inhibit
could
detriment
effect
intent
overcom
target
bad
mmp
via
hyperselect
substrat
profil
fell
short
basi
tissu
destruct
repair
mediat
mmp
eg
depend
acuiti
diseas
given
time
point
howev
one
exampl
translat
knowledg
role
mmp
ms
minocyclin
tetracyclin
antibiot
exert
broadspectrum
inhibit
mmp
demonstr
two
phase
studi
ms
efficaci
reduc
gadoliniumenhanc
lesion
encourag
studi
group
execut
phase
clinic
trial
patient
first
ms
attack
clinic
mri
find
suggest
minocyclin
comparison
placebo
reduc
risk
patient
first
attack
reach
criteria
formal
ms
diagnosi
within
month
p
site
primari
action
minocyclin
like
peripheri
ie
immun
system
outsid
cn
known
mmp
inhibit
respons
clinic
effect
anoth
potenti
mode
action
apart
direct
inhibit
enzymat
activ
sever
mmp
interfer
activ
emmprin
extracellular
matrix
metalloproteinas
induc
membran
glycoprotein
immunoglobulin
superfamili
whose
level
reduc
cell
minocyclin
thu
minocyclin
treatment
like
reduc
activ
secondarili
releas
product
mmp
result
diminish
leukocyt
extravas
leukocyt
cn
canadian
studi
group
run
minocyclin
trial
ms
far
prepar
current
anoth
trial
yong
vw
person
commun
sever
frequenc
relaps
import
determin
longterm
outcom
ms
steroid
current
standard
intervent
therapi
attenu
acut
exacerb
ms
howev
effect
disabl
develop
limit
power
compound
situat
repres
high
unmet
medic
need
effect
hydroxam
acid
type
mmpi
eae
strong
preclin
evid
use
acut
exacerb
ms
broadspectrum
mmpi
obviou
drug
candid
given
array
mmp
upregul
condit
shown
free
side
effect
dose
period
sever
day
despit
health
author
defin
develop
path
develop
compound
relaps
therapi
pharmaceut
industri
far
engag
develop
activ
howev
may
opportun
second
life
class
candid
drug
metalloproteinas
mediat
neuroinflammatori
process
upon
neuroinfect
ms
neuroinflammatori
diseas
metalloproteinas
regul
bbb
breakdown
neutrophil
infiltr
cytokin
signal
metalloproteinas
inhibitor
experiment
shown
decreas
neuroinflamm
brain
damag
diseas
excess
neuroinflamm
common
denomin
therebi
improv
outcom
diseas
nevertheless
time
metalloproteinas
inhibit
appear
critic
effect
downmodul
cascad
pathophysiolog
process
lead
brain
damag
pm
hand
metalloproteinas
also
mediat
neuroregener
synaptogenesi
process
therapeut
intend
inhibit
critic
role
metalloproteinas
neuron
repair
mechan
regener
late
recogn
origin
idea
chronic
mmp
inhibit
need
conceptu
revis
recent
accumul
research
urg
second
chanc
mmpi
whichwhen
correctli
appli
dosedharbor
potenti
improv
mani
differ
neuroinflammatori
diseas
